KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS

Ambrogio, Chiara, Köhler, Jens, Zhou, Zhi-Wei, Wang, Haiyun, Paranal, Raymond, Li, Jiaqi, Capelletti, Marzia, Caffarra, Cristina +9 more·2018·Cell

DOI 10.1016/j.cell.2017.12.020

Cited by (272)

Items 101–200 of 272

Computer-Aided Drug Design Boosts RAS Inhibitor Discovery
Ge Wang, Yuhao Bai, Jiarui Cui, Zirui Zong, Yuan Gao, Zhen Zheng · 2022 · Molecules
Critical requirement of SOS1 for tumor development and microenvironment modulation in KRASG12D-driven lung adenocarcinoma
Fernando C. Baltanás, Rósula García‐Navas, Pablo Rodríguez-Ramos, Nuria Calzada, Cristina Cuesta, Javier Borrajo, Rocío Fuentes‐Mateos, Andrea Olarte-San Juan, Nerea Vidaña, Esther Castellano et al. · 2023 · Nature Communications
The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer
Rodrigo Entrialgo‐Cadierno, Cristina Cueto‐Ureña, Connor Welch, Iker Feliu, Irati Macaya, Laura Vera, Xabier Morales, Sandra Vietti Michelina, Pietro Scaparone, Inés López et al. · 2023 · Molecular Cancer
Stromal-derived NRG1 enables oncogenic KRAS bypass in pancreas cancer
Jincheng Han, Jiaqian Xu, Yonghong Liu, Shaoheng Liang, Kyle A. LaBella, Deepavali Chakravarti, Denise J. Spring, Yan Xia, Ronald Anthony DePinho · 2023 · Genes & Development
Monobodies as tool biologics for accelerating target validation and druggable site discovery
Padma Akkapeddi, Kai Wen Teng, Shohei Koide · 2021 · RSC Medicinal Chemistry
Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stone
Alexander B. Coley, Antonio Ward, Adam B. Keeton, Xi Chen, Yulia Y. Maxuitenko, Aishwarya Prakash, Feng Li, Jeremy B. Foote, Donald J. Buchsbaum, Gary Anthony Piazza · 2022 · Advances in cancer research
RASSF9 promotes NSCLC cell proliferation by activating the MEK/ERK axis
Jun Jie Yuan, Qianqian Ju, Jun Zhu, Yun Jiang, Xuechao Yang, Xiaoyu Liu, Jinyu Ma, Cheng Sun, Jiahai Shi · 2021 · Cell Death Discovery
Structural insights into Ras regulation by SIN1
Yuyuan Zheng, Lei Ding, Xianhui Meng, Meg Potter, Alison L. Kearney, Jie Zhang, Jie Sun, David Ernest James, Guang Yang, Chun Zhou · 2022 · Proceedings of the National Academy of Sciences
How Anionic Lipids Affect Spatiotemporal Properties of KRAS4B on Model Membranes.
Van A. Ngo, Sumantra Sarkar, Chris Neale, A. Garcia · 2020 · Journal of Physical Chemistry B
BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy
Marcel Wiesweg, Cedric Preuß, Julia Roeper, Martin Metzenmacher, Wilfried Eberhardt, Ursula Stropiep, Katrin Wedeken, Henning Reis, Thomas Herold, Kaid Darwiche et al. · 2021 · European Journal of Cancer
Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants
Imran Khan, Akiko Koide, Mariyam Zuberi, Gayatri Ketavarapu, Eric Denbaum, Kai Wen Teng, Joshua Matthew Rhett, Russell Spencer-Smith, G. Aaron Hobbs, Ernest Ramsay Camp et al. · 2022 · Cell Reports
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo
Arafath Kaja Najumudeen, Sigrid K. Fey, Laura M. Millett, Catriona A. Ford, Kathryn L. Gilroy, Nuray Gündüz, Rachel A. Ridgway, Eve Anderson, Douglas Strathdee, William Andrew Clark et al. · 2024 · Nature Communications
Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1
April Lo, Kristin Holmes, Shriya Kamlapurkar, Filip Mundt, Sitapriya Moorthi, Iris Fung, Shaunt Fereshetian, Jacqueline Watson, Steven A. Carr, Philipp Mertins et al. · 2021 · Science Signaling
Direct GDP-KRAS G12C inhibitors and mechanisms of resistance: the tip of the iceberg
Joshua C. Rosen, Adrian G. Sacher, Ming‐Sound Tsao · 2023 · Therapeutic Advances in Medical Oncology
Methionine 170 is an Environmentally Sensitive Membrane Anchor in the Disordered HVR of K-Ras4B
Chris Neale, Angel E. Garcı́a · 2018 · The Journal of Physical Chemistry B
Derivation of a new model of lung adenocarcinoma using canine lung cancer organoids for translational research in pulmonary medicine
Yomogi Shiota, Mohamed Elbadawy, Kazuhiko Suzuki, Ryouichi Tsunedomi, Hiroaki Nagano, Yusuke Ishihara, Haru Yamamoto, Daigo Azakami, Tsuyoshi Uchide, Ryuji Fukushima et al. · 2023 · Biomedicine & Pharmacotherapy
Rationally Designed Dual Base Pair Mismatch Enables Toehold-Mediated Strand Displacement to Efficiently Recognize Single-Nucleotide Polymorphism without Enzymes
Yunshan Zhang, Lanyue Wang, Jing Ye, Jian Chen, Shijie Xu, Sisi Bu, Minxin Deng, Lina Bian, Xiaoyu Zhao, Chunlong Zhang et al. · 2023 · Analytical Chemistry
Copy number losses of oncogenes and gains of tumor suppressor genes generate common driver mutations
Elizaveta G. Besedina, Fran Supek · 2024 · Nature Communications
Analysis of RAS protein interactions in living cells reveals a mechanism for pan-RAS depletion by membrane-targeted RAS binders
Yao-Cheng Li, Nikki K. Lytle, Seth T. Gammon, Luke Wang, Tikvah K. Hayes, Margie Nicole Sutton, Robert C. Bast, Channing J. Der, David R Piwnica-Worms, Frank P. McCormick et al. · 2020 · Proceedings of the National Academy of Sciences
RAS Nanoclusters Selectively Sort Distinct Lipid Headgroups and Acyl Chains
Yong Zhou, Alemayehu Abebe Gorfe, John F. Hancock · 2021 · Frontiers in Molecular Biosciences
Organization of Farnesylated, Carboxymethylated KRAS4B on Membranes
Eric Barklis, Andrew G. Stephen, August O. Staubus, Robin Lid Barklis, Ayna Alfadhli · 2019 · Journal of Molecular Biology
MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression
Dylan Farnsworth, Yusuke Inoue, Fraser D. Johnson, Georgia de Rappard-Yuswack, Daniel Lu, Rocky Shi, Lok In Josephine Ma, Marissa S. Mattar, Romel Somwar, Marc Ladanyi et al. · 2022 · npj Precision Oncology
Principles and characteristics of biological assemblies in experimentally determined protein structures
Qifang Xu, Roland L. Dunbrack · 2019 · Current Opinion in Structural Biology
Inhibition of RAS: proven and potential vulnerabilities
Mariyam Zuberi, Imran Khan, John P. O’Bryan · 2020 · Biochemical Society Transactions
Cell‐permeable CaaX‐peptides affect K‐Ras downstream signaling and promote cell death in cancer cells
Annika Klimpel, Katharina Stillger, Janica L. Wiederstein, Marcus Krüger, Ines Neundorf · 2020 · FEBS Journal
Loss of wild type KRAS in KRAS lung adenocarcinoma is associated with cancer mortality and confers sensitivity to FASN inhibitors
Yan Liu, Galen F. Gao, John Dorrance Minna, Noelle Sevilir Williams, Kenneth D. Westover · 2021 · Lung Cancer
Hetero-oligomerization of Rho and Ras GTPases Connects GPCR Activation to mTORC2-AKT Signaling
Hiroshi Senoo, May Wai, Hideaki T. Matsubayashi, Hiromi Sesaki, Miho Iijima · 2020 · Cell Reports
Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives
Renata Tisi, Vadim Gaponenko, Marco Vanoni, Elena Sacco · 2020 · Biomolecules
The Hypervariable Region of K-Ras4B Governs Molecular Recognition and Function
Hazem Abdelkarim, Avik Banerjee, Patrick K. Grudzien, Nicholas Leschinsky, Mahmoud Abushaer, Vadim Gaponenko · 2019 · International Journal of Molecular Sciences
Oncogenic K-Ras4B Dimerization Enhances Downstream Mitogen-activated Protein Kinase Signaling
Serena Muratcioğlu, Cihan Aydın, Ezgi Odabasi, E. Sıla Özdemir, Elif Nur Firat‐Karalar, Hyunbum Jang, Chung‐Jung Tsai, Ruth Nussinov, İbrahim Halil Kavaklı, Attila Gürsoy et al. · 2020 · Journal of Molecular Biology
Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
Elisa Baldelli, Emna El Gazzah, John Conor Moran, Kimberley Alex Hodge, Zarko Manojlovic, Rania Bassiouni, John David Carpten, Vienna Ludovini, Sara Baglivo, Lucio Crinò et al. · 2021 · Genes
The Self‐Association of the KRAS4b Protein is Altered by Lipid‐Bilayer Composition and Electrostatics
Ki‐Young Lee, Mitsuhiko Ikura, Christopher B. Marshall · 2023 · Angewandte Chemie International Edition
Progress in RAS‐targeted therapeutic strategies: From small molecule inhibitors to proteolysis targeting chimeras
Xinchen Lu, Jinmei Jin, Ye Wu, Xiaoxia Liu, Xiaohui Liang, Jiayi Lin, Qingyan Sun, Jiang‐Jiang Qin, Weidong Zhang, Xin Luan · 2023 · Medicinal Research Reviews
Bispecific, Exosome‐Mimetic Lipid Nanoparticles Facilitate Dual siRNAs for Synergistic Therapy against Pancreatic Cancer
Qian Wang, Zhen Zhang, Zihua Wang, Jingyun Wang, Yongbo Ren, Xiaodan Sun, Jie Tian, Feiyu Kang, Xinming Zhao, Hao Yan · 2024 · Advanced Functional Materials
Correlation of O2 transport on the micro and macro scale.
Carl R. Honig, T. E. Gayeski · 1982 · PubMed
Synthesis of the PET Tracer 124I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring
Edwin C. Pratt, Elizabeth L. Isaac, Evan P. Stater, Guangbin Yang, Ouathek Ouerfelli, Nagavarakishore Pillarsetty, Jan Grimm · 2020 · Journal of Nuclear Medicine
Conquering oncogenic KRAS and its bypass mechanisms
Pingping Hou, Yanru Wang · 2022 · Theranostics
Influence of Cholesterol on the Orientation of the Farnesylated GTP-Bound KRas-4B Binding with Anionic Model Membranes
Huixia Lu, Jordi Martı́ · 2020 · Membranes
RAS Dimers: The Novice Couple at the RAS-ERK Pathway Ball
Ana Herrero, Piero Crespo · 2021 · Genes
D154Q Mutation does not Alter KRAS Dimerization
Ingrid Grozavu, Sarah E. Stuart, Anna Lyakisheva, Zhong Yao, Shivanthy Pathmanathan, Michael Ohh, Igor Štagljar · 2021 · Journal of Molecular Biology
Predicting the conformational variability of oncogenic GTP-bound G12D mutated KRas-4B proteins at zwitterionic model cell membranes
Huixia Lu, Jordi Martı́ · 2022 · Nanoscale
Mutations in the α4-α5 allosteric lobe of RAS do not significantly impair RAS signaling or self-association
Michael Whaby, Lauren Wallon, Megan Mazzei, Imran Khan, Kai Wen Teng, Shohei Koide, John P. O’Bryan · 2022 · Journal of Biological Chemistry
Martini 3 Force Field Parameters for Protein Lipidation Post-Translational Modifications
Panagiotis I. Koukos, Sepehr Dehghani‐Ghahnaviyeh, Camilo Velez‐Vega, John I. Manchester, D. Peter Tieleman, José S. Duca, Paulo C. T. Souza, Zoe Cournia · 2023 · Journal of Chemical Theory and Computation
Conditional Cooperativity in RAS Assembly Pathways on Nanodiscs and Altered GTPase Cycling
Soo‐Yeon Lee, Ki‐Young Lee · 2024 · Angewandte Chemie International Edition
Targeting the KRAS α4-α5 allosteric interface inhibits pancreatic cancer tumorigenesis
Imran Khan, Catherine B. MarElia, Julia E. Lefler, Mariyam Zuberi, Eric Denbaum, Akiko Koide, Dean M. Connor, Ann‐Marie Broome, Thierry Pécot, Cynthia Dawn Timmers et al. · 2021 · Small GTPases
KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients
Shuhang Wang, Qin Li, Peiwen Ma, Yuan Fang, Yue Yu, Ning Jiang, Huilei Miao, Qiyu Tang, Yuqi Yang, Shujun Xing et al. · 2022 · Frontiers in Molecular Biosciences
Increased mutant KRAS gene dosage drives pancreatic cancer progression: evidence for wild-type KRAS as a tumor suppressor?
Oliver A. Kent · 2018 · HepatoBiliary Surgery and Nutrition
Therapeutic Targeting the Allosteric Cysteinome of RAS and Kinase Families
Li, Lianbo, Meyer, Cynthia, Zhou, Zhi-Wei, Elmezayen, Ammar, Westover, Kenneth · 2022 · Journal of Molecular Biology
Two Distinct Structures of Membrane‐Associated Homodimers of GTP‐ and GDP‐Bound KRAS4B Revealed by Paramagnetic Relaxation Enhancement
Ki‐Young Lee, Zhenhao Fang, Masahiro Enomoto, Geneviève M. C. Gasmi-Seabrook, Le Zheng, Shohei Koide, Mitsuhiko Ikura, Christopher B. Marshall · 2020 · Angewandte Chemie
Millisecond molecular dynamics simulations of KRas-dimer formation and interfaces
Van A. Ngo, Angel E. Garcı́a · 2022 · Biophysical Journal
Assembling defined DNA nanostructures with anticancer drugs: a metformin/DNA complex nanoplatform with a synergistic antitumor effect for KRAS-mutated lung cancer therapy
Hang Qian, Dong Wang, Binfeng He, Qian Liu, Yü Xu, Di Wu, Chunfa Chen, Wen Zhang, David Tai Leong, Guansong Wang · 2022 · NPG Asia Materials
How to manage KRAS G12C-mutated advanced non-small-cell lung cancer
Biagio Ricciuti, Alessia Mira, Elisa Andrini, Pietro Scaparone, Sandra Vietti Michelina, Federica Pecci, Luca Cantini, Andrea De Giglio, Giuseppe Lamberti, Chiara Ambrogio et al. · 2022 · Drugs in Context
SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRAS G12D inhibitor in KRAS LUAD
Fernando C. Baltanás, Maximilian Kramer‐Drauberg, Rósula García‐Navas, Enrico Patrucco, Ettore Petrini, Heribert Arnhof, Andrea Olarte-San Juan, Pablo Rodríguez-Ramos, Javier Borrajo-Sánchez, Nuria Calzada et al. · 2025 · Proceedings of the National Academy of Sciences
Modeling and subtleties of K-Ras and Calmodulin interaction
Eduardo Garrido, Juan Lázaro, Montserrat Jaumot, Neus Agell, J. Rubio · 2018 · PLoS Computational Biology
RASless MEFs as a Tool to Study RAS-Dependent and RAS-Independent Functions
Carmen G. Lechuga, Marina Salmón, Guillem Paniagua, Carmen E. Guerra, Mariano Barbacid, Matthias Drosten · 2021 · Methods in molecular biology
Effector Binding Sequentially Alters KRAS Dimerization on the Membrane: New Insights Into RAS‐Mediated RAF Activation
Soo‐Yeon Lee, Hyun-Jong Eun, Ki‐Young Lee · 2024 · Advanced Science
Capturing RAS oligomerization on a membrane
Sangho D. Yun, Elena Scott, Jing‐Yuan Chang, Hanieh Bahramimoghaddam, Michael Lynn, Carter Lantz, David H. Russell, Arthur D. Laganowsky · 2024 · Proceedings of the National Academy of Sciences
KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition
Sigrid K. Fey, Arafath Kaja Najumudeen, Dale M. Watt, Laura M. Millett, Catriona A. Ford, Kathryn L. Gilroy, Rosalin J. Simpson, Kathy McLay, Rosanna Upstill‐Goddard, David Kuang-Fu Chang et al. · 2024 · Cancer Research
Ras Multimers on the Membrane: Many Ways for a Heart-to-Heart Conversation
E. Sıla Özdemir, Anna Magdalena Koester, Xiaolin Nan · 2022 · Genes
An in vitro BRAF activation assay elucidates molecular mechanisms driving disassembly of the autoinhibited BRAF state
Daniel A. Ritt, David Durrant, Matthew R. Drew, Suzanne I. Sandin, Juliana A. Martinez Fiesco, Xiao‐Hua Zhang, Fikret Aydin, Timothy S. Carpenter, Grace M. Scheidemantle, Robert A. D’Ippolito et al. · 2025 · Proceedings of the National Academy of Sciences
Membrane Composition and Raf[CRD]-Membrane Attachment Are Driving Forces for K-Ras4B Dimer Stability
Ioannis Andreadelis, Sofia Kiriakidi, Christos Lamprakis, Anastasia Theodoropoulou, Stefan Doerr, Alexios Chatzigoulas, John I. Manchester, Camilo Velez‐Vega, José S. Duca, Zoe Cournia · 2022 · The Journal of Physical Chemistry B
Membrane-Driven Dimerization of the Peripheral Membrane Protein KRAS: Implications for Downstream Signaling
Ki‐Young Lee · 2024 · International Journal of Molecular Sciences
Presence or Absence of Ras Dimerization Shows Distinct Kinetic Signature in Ras-Raf Interaction
Sumantra Sarkar, Angel E. Garcı́a · 2020 · Biophysical Journal
Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer
Daniel R. Goulet, Joseph P. Foster, Jon S. Zawistowski, Samantha M. Bevill, Mélodie P. Noël, José F. Olivares-Quintero, Noah Sciaky, Darshan Singh, Charlene Santos, Samantha G. Pattenden et al. · 2020 · Molecular Cancer Research
Brother’s Keeper: Wild-Type Mutant K-Ras Dimers Limit Oncogenesis
Yi-Jang Lin, Kevin M. Haigis · 2018 · Cell
Convergent genetic aberrations in murine and human T lineage acute lymphoblastic leukemias
Benjamin J. Huang, Anica M. Wandler, Lauren K. Meyer, Monique Dail, Anneleen Daemen, Deepak Sampath, Qing Li, Xinyue Wang, Jasmine C. Y. Wong, Joy Nakitandwe et al. · 2019 · PLoS Genetics
Direct KRAS inhibition: progress, challenges, and a glimpse into the future
Dimitra Grapsa, Konstantinos Syrigos · 2020 · Expert Review of Anticancer Therapy
Combined GSK-3β and MEK inhibitors modulate the stemness and radiotherapy sensitivity of cervical cancer stem cells through the Wnt signaling pathway
Cong Wang, Lijun Liu, Yan Cheng, Huirong Shi · 2023 · Chemico-Biological Interactions
The ubiquitin code of RAS proteins: Decoding its role in cancer progression
Yedan Shi, Yong Shen, Xiuyuan Zhang, Ning Wen Zhu, Yuwei Ding, Ying Yuan, Juan Wang · 2025 · iScience
If Virchow and Ehrlich Had Dreamt Together: What the Future Holds for KRAS-Mutant Lung Cancer
Jens Köhler, Pasi Antero Janne · 2021 · International Journal of Molecular Sciences
Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung Adenocarcinoma
Peng Lin, Wei Cheng, Xin Qi, Pinglu Zhang, Jianshe Xiong, Jing Li · 2024 · International Journal of Molecular Sciences
Experimental variables determine the outcome of RAS-RAS interactions
Zhiwei Zhou, Tra-Ly Nguyen, Xing-Xiao Li, Christel Poujol, Ewa Berlinska, Sandra Vietti Michelina, Jonas N. Kapp, Andreas Plückthun, Monte M. Winslow, Chiara Ambrogio et al. · 2024 · Journal of Biological Chemistry
TargetingKRAS G12Cmutations in colorectal cancer
Minghe Zhao, Aiwen Wu · 2022 · Gastroenterology report
Ras/MAPK signalling intensity defines subclonal fitness in a mouse model of hepatocellular carcinoma
Anthony Lozano, Francois-Regis Souche, Carine Chavey A, Valérie Dardalhon, Christel F. A. Ramirez, Serena Vegna, Guillaume Desandré, Anaïs Riviere, Amal Zine El Aabidine, Philippe Fort et al. · 2023 · eLife
Exploring the Lapse in Druggability: Sequence Analysis, Structural Dynamics and Binding Site Characterization of K-RasG12C Variant, a Feasible Oncotherapeutics Target
Emmanuel A. Adeniji, Fisayo Andrew Olotu, Mahmoud E. S. Soliman · 2018 · Anti-Cancer Agents in Medicinal Chemistry
Cancer cell killing by target antigen engagement with engineered complementary intracellular antibody single domains fused to pro-caspase3
Jennifer S. Chambers, Tim Brend, Terence Howard Rabbitts · 2019 · Scientific Reports
Ras Variant Biology and Contributions to Human Disease
Ian A. Prior · 2021 · Methods in molecular biology
Wild-type RAS signaling is an essential therapeutic target in RAS -mutated cancers
Nancy E. Sealover, Bridget A. Finniff, Jacob M. Hughes, Erin Sheffels, Hyun Lee, Joseph P. LaMorte, Vainavi Gambhir, Zaria Beckley, Amanda J. Linke, Matthew D. Wilkerson et al. · 2025 · Science Signaling
gRASping the redox lever to modulate cancer cell fate signaling
Chuan Han Jonathan Foo, Shazib Pervaiz · 2018 · Redox Biology
Probing Colocalization of N‐Ras and K‐Ras4B Lipoproteins in Model Biomembranes
Lie Li, Mridula Dwivedi, Satyajit Patra, Nelli Erwin, Simone Möbitz, Roland Winter · 2019 · ChemBioChem
Discoveries in the redox regulation of KRAS
Maximilian Kramer‐Drauberg, Chiara Ambrogio · 2020 · The International Journal of Biochemistry & Cell Biology
Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation
Panyu Chen, Benjamin J. Huang, Max Harris, Christopher D. Boone, Weijie Wang, Heidi Carias, Brian Mesiona, Daniela Mavrici, Amanda C. Kohler, Gideon E. Bollag et al. · 2023 · JCI Insight
It Takes Two To Target: A Study in KRAS Dimerization
Behnam Nabet, Nathanael S. Gray · 2018 · Biochemistry
Mutant Kras Dosage and Chromothripsis: The Right Ingredients for a Pancreatic Cancer Catastrophe
Francisco X. Real, Mónica P. de Andrés · 2018 · Trends in cancer
EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy
Atsuko Ogino, Amir Vajdi, Xinmeng Jasmine Mu, Navin R. Mahadevan, Kenneth H. Ngo, Matthew Aaron Booker, Paloma Cejas, Jeffrey J. Okoro, Man Xu, Benjamin F. Springer et al. · 2026 · JCI Insight
Evaluation of RAS Mutational Status in Liquid Biopsy to Monitor Disease Progression in Metastatic Colorectal Cancer Patients
Elena Lastraioli, Alessandra Bettiol, Jessica Iorio, Elvira Limatola, Daniele Checcacci, Erica Parisi, Cristina Bianchi, Annarosa Arcangeli, Mauro Iannopollo, Francesco Di Costanzo et al. · 2023 · Cells
Crystal Packing Reveals a Potential Autoinhibited KRAS Dimer Interface and a Strategy for Small-Molecule Inhibition of RAS Signaling
Robert J. Brenner, Alexander D. Landgraf, Khuchtumur Bum‐Erdene, Giovanni González-Gutiérrez, Samy O. Meroueh · 2023 · Biochemistry
Role of silent mutations in KRAS-mutant tumors
Jun Guo Lu, Chao Zhou, Feng Pan, Hongyu Liu, Haohua Jiang, Hua Zhong, Baohui Han · 2024 · Chinese Medical Journal
Systems biology approaches to macromolecules: the role of dynamic protein assemblies in information processing
Oleksii S. Rukhlenko, Boris Ν. Kholodenko, Walter Kölch · 2020 · Current Opinion in Structural Biology
2-Pyridin-4-yl-methylene-beta-boswellic Acid─A Potential Candidate for Targeting O6-Methylguanine-DNA Methyltransferase Epi-transcriptional Reprogramming in KRAS G13D─Microsatellite Stable, G12V─Microsatellite Instable Mutant Colon Cancer
Arem Qayum, Jasvinder Singh, Arvind Kumar, Syed Mohmad Shah, Shubham Srivastava, Manoj Kushwaha, Asmita Magotra, Utpal Nandi, Ruchi Malik, Bhahwal Ali Shah et al. · 2022 · ACS Pharmacology & Translational Science
Oncogenic Signalling of Growth Factor Receptors in Cancer: Mechanisms and Therapeutic Opportunities
Anica Dricu · 2022 · International Journal of Molecular Sciences
RAS: Circuitry and therapeutic targeting
Gagandeep Singh, Neelam Thakur, Umesh Kumar · 2022 · Cellular Signalling
α4-α5 Helices on Surface of KRAS Can Accommodate Small Compounds That Increase KRAS Signaling While Inducing CRC Cell Death
Baraa Abuasaker, Eduardo Garrido, Marta Vilaplana, Jesús Daniel Gómez-Zepeda, Sònia Brun, Marta Garcia‐Cajide, Caroline Mauvezin, Montserrat Jaumot, María Dolors Pujol, J. Rubio et al. · 2023 · International Journal of Molecular Sciences
Water in Ras Superfamily Evolution
Kendra Marcus, Carla Mattos · 2019 · Journal of Computational Chemistry
Functional measurement of mitogen-activated protein kinase pathway activation predicts responsiveness of RAS-mutant cancers to MEK inhibitors
Shumei Kato, Robert Porter, Ryosuke Okamura, Suzanna Lee, Ori Zelichov, Gabi Tarcic, Michael Vidne, Razelle Kurzrock · 2021 · European Journal of Cancer
Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitors
Aradhya Nigam, Gnana Prakasam Krishnamoorthy, Walid Khaled Chatila, Katherine Berman, Mahesh Saqcena, Henry S. Walch, Mandakini Venkatramani, Alan Loh Ho, Nikolaus D. Schultz, James A. Fagin et al. · 2024 · Oncogene
RAS–membrane interaction and oligomerization: there is more than meets the eye
Abraham C. Sianoya, Vijay Kumar Bhardwaj, Alemayehu Abebe Gorfe · 2025 · Biochemical Society Transactions
Diffusion-based determination of protein homodimerization on reconstituted membrane surfaces
Tyler A. Jepson, Jean K. Chung · 2021 · BMB Reports
Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients
Qianhe Ren, Qifan Li, Chenye Shao, Pengpeng Zhang, Zhuangzhuang Hu, Jun Li, Wei Ting Wang, Yue Yu · 2023 · BMC Cancer
Novel druggable space in human KRAS G13D discovered using structural bioinformatics and a P-loop targeting monoclonal antibody
Oscar Jungholm, Carolina L. Trkulja, Martin Moche, Sreesha P. Srinivasa, Maria-Nefeli Christakopoulou, Max Davidson, Anna Reymer, Kent E. Jardemark, Rafaela L Fogaça, Anaswara Ashok et al. · 2024 · Scientific Reports